REVIEW
Published on 21 Mar 2024
Advancements in PSMA ligand radiolabeling for diagnosis and treatment of prostate cancer: a systematic review
doi 10.3389/fonc.2024.1373606
- 2,257 views
- 2 citations
- Frontiers in Oncology
- Genitourinary Oncology
- Research Topics
- Radioligand Therapy in Prostate Cancer
Radioligand Therapy in Prostate Cancer
2,879
Total downloads
11k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 08 Mar 2024
Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient
doi 10.3389/fonc.2024.1331643
- 1,364 views
- 1 citation
CASE REPORT
Published on 11 Dec 2023
Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer
doi 10.3389/fonc.2023.1289272
- 1,150 views
- 2 citations
CASE REPORT
Published on 28 Apr 2023
Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient
doi 10.3389/fonc.2023.1192792
- 3,277 views
- 3 citations
ORIGINAL RESEARCH
Published on 18 Jan 2023
Theranostic 64Cu-DOTHA2-PSMA allows low toxicity radioligand therapy in mice prostate cancer model
doi 10.3389/fonc.2023.1073491
- 2,032 views
- 2 citations
Published in
Frontiers in Oncology
- Genitourinary Oncology
Impact
- 11kTopic views
- 7,860Article views
- 2,879Article downloads